{{Rsnum
|rsid=3024622
|Gene=IL4R
|Chromosome=16
|position=27354132
|Orientation=plus
|GMAF=0.3393
|Gene_s=IL4R
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 43.1 | 43.1 | 13.8
| HCB | 40.0 | 42.2 | 17.8
| JPT | 20.5 | 47.7 | 31.8
| YRI | 74.6 | 22.2 | 3.2
| ASW | 0.0 | 0.0 | 0.0
| CHB | 40.0 | 42.2 | 17.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22541248
|Title=IL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti-IL-4 receptor α antagonist
|OA=1
}}{{PMID Auto
|PMID=19956098
|Title=Association analysis of SNPs in the IL4R locus with type I diabetes.
|OA=1
}}

{{PMID Auto
|PMID=19956101
|Title=Overview of the Rapid Response data.
|OA=1
}}

{{PMID Auto
|PMID=20031590
|Title=The relation of genetic and environmental factors to systemic inflammatory biomarker concentrations.
|OA=1
}}